357 related articles for article (PubMed ID: 28698330)
1. Clinical characteristics of importance to outcome in patients with axial spondyloarthritis: protocol for a prospective descriptive and exploratory cohort study.
Andreasen RA; Kristensen LE; Ellingsen T; Christensen R; Baraliakos X; Wied J; Aalykke C; Ulstrup T; Schiøttz-Christensen B; Horn HC; Emamifar A; Duerlund B; Fischer L; Hansen IMJ
BMJ Open; 2017 Jul; 7(7):e015536. PubMed ID: 28698330
[TBL] [Abstract][Full Text] [Related]
2. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
3. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
[TBL] [Abstract][Full Text] [Related]
4. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
[TBL] [Abstract][Full Text] [Related]
5. The impact of sex and disease classification on patient-reported outcome measures in axial spondyloarthritis: a descriptive prospective cross-sectional study.
Andreasen RA; Kristensen LE; Egstrup K; Baraliakos X; Strand V; Horn HC; Hansen IMJ; Christensen R; Ellingsen T
Arthritis Res Ther; 2019 Oct; 21(1):221. PubMed ID: 31665083
[TBL] [Abstract][Full Text] [Related]
6. Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome.
Corli J; Flipo RM; Philippe P; Bera-Louville A; Béhal H; Wibaux C; Paccou J
J Rheumatol; 2015 Dec; 42(12):2376-82. PubMed ID: 26568593
[TBL] [Abstract][Full Text] [Related]
7. Management of Axial Spondyloarthritis - Insights into Upadacitinib.
Braun J; Kiltz U; Baraliakos X
Drug Des Devel Ther; 2022; 16():3609-3620. PubMed ID: 36268520
[TBL] [Abstract][Full Text] [Related]
8. Certolizumab pegol for treating axial spondyloarthritis.
Desmarais J; Beier S; Deodhar A
Expert Opin Biol Ther; 2016 Aug; 16(8):1059-64. PubMed ID: 27366922
[TBL] [Abstract][Full Text] [Related]
9. Neuropathic pain in axial spondyloarthropathy is underdiagnosed and a confounding factor in biologic drug-switching decision: a cross-sectional study.
Öğüt TS; Erbasan F; Terzioğlu ME; Aslan B; Çelik E; Yazisiz V
Clin Rheumatol; 2023 May; 42(5):1275-1284. PubMed ID: 36746834
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Adalimumab in Non-radiographic Axial Spondyloarthritis: Evaluation of Clinical and Magnetic Resonance Imaging Outcomes in a Monocentric Cohort.
Cantarini L; Fabbroni M; Talarico R; Costa L; Caso F; Cuneo GL; Frediani B; Faralli G; Vitale A; Brizi MG; Sabadini L; Galeazzi M
Medicine (Baltimore); 2015 Jul; 94(30):e1170. PubMed ID: 26222847
[TBL] [Abstract][Full Text] [Related]
11. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?
Kiltz U; Baraliakos X; Karakostas P; Igelmann M; Kalthoff L; Klink C; Krause D; Schmitz-Bortz E; Flörecke M; Bollow M; Braun J
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1415-22. PubMed ID: 22505331
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Non-radiographic Axial Spondyloarthritis and Ankylosing Spondyltis from a Single Rheumatology Hospital in Morocco.
Akasbi N; Nihad S; Sofia Z; Khadija EK; Taoufik H
Curr Rheumatol Rev; 2020; 16(3):240-244. PubMed ID: 30806321
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis.
Baraliakos X; Kiltz U; Peters S; Appel H; Dybowski F; Igelmann M; Kalthoff L; Krause D; Menne HJ; Saracbasi-Zender E; Schmitz-Bortz E; Vigneswaran M; Braun J
Rheumatology (Oxford); 2017 Jan; 56(1):95-102. PubMed ID: 27997346
[TBL] [Abstract][Full Text] [Related]
14. Gait as predictor of physical function in axial spondyloarthritis: the prospective longitudinal FOLOMI (Function, Locomotion, Measurement, Inflammation) study protocol.
Soulard J; Vuillerme N; Gaudin P; Grange L; Baillet A; Cracowski JL; Juvin R; Vaillant J
Rheumatol Int; 2019 Oct; 39(10):1681-1688. PubMed ID: 31392500
[TBL] [Abstract][Full Text] [Related]
15. Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.
Wallman JK; Kapetanovic MC; Petersson IF; Geborek P; Kristensen LE
Arthritis Res Ther; 2015 Dec; 17():378. PubMed ID: 26703005
[TBL] [Abstract][Full Text] [Related]
16. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
van der Heijde D; Dougados M; Landewé R; Sieper J; Maksymowych WP; Rudwaleit M; Van den Bosch F; Braun J; Mease PJ; Kivitz AJ; Walsh J; Davies O; Bauer L; Hoepken B; Peterson L; Deodhar A
Rheumatology (Oxford); 2017 Sep; 56(9):1498-1509. PubMed ID: 28498975
[TBL] [Abstract][Full Text] [Related]
17. Chronic Pain and Assessment of Pain Sensitivity in Patients With Axial Spondyloarthritis: Results From the SPARTAKUS Cohort.
Mogard E; Olofsson T; Bergman S; Bremander A; Kristensen LE; Olsen JK; Wallman JK; Lindqvist E
J Rheumatol; 2021 Nov; 48(11):1672-1679. PubMed ID: 33323532
[TBL] [Abstract][Full Text] [Related]
18. Does a short course of etanercept influence disease progression and radiographic changes in patients suspected of non-radiographic axial spondyloarthritis? Three -years follow- up of a placebo-controlled trial.
Rusman T; van der Weijden M; Nurmohamed MT; van Denderen CJ; Landewé R; Bet PM; Bijl CV; van der Laken CJ; van der Horst-Bruinsma IE
Scand J Rheumatol; 2023 Mar; 52(2):137-141. PubMed ID: 35543102
[TBL] [Abstract][Full Text] [Related]
19. Advances in pharmacotherapies for axial spondyloarthritis.
Toussirot E
Expert Opin Pharmacother; 2023; 24(13):1439-1448. PubMed ID: 37318776
[TBL] [Abstract][Full Text] [Related]
20. Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics.
Sieper J; Rudwaleit M; Lenaerts J; Wollenhaupt J; Myasoutova L; Park SH; Song YW; Yao R; Huyck S; Govoni M; Chitkara D; Vastesaeger N
Rheumatology (Oxford); 2016 Nov; 55(11):1946-1953. PubMed ID: 27411482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
